| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Majors Cary L | SVP and President, Healthcare | C/O 70 SIR JOHN ROGERSON'S QUAY, DUBLIN, IRELAND | /s/ John P. Ubbing, Authorized Representative under Power of Attorney | 22 May 2025 | 0001776271 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | STE | Ordinary Shares | Options Exercise | $1,886,357 | +12,828 | +113% | $147.05 | 24,200 | 20 May 2025 | Direct | F1 |
| transaction | STE | Ordinary Shares | Sale | $2,059,523 | -8,247 | -34% | $249.73 | 15,953 | 20 May 2025 | Direct | F1, F2 |
| transaction | STE | Ordinary Shares | Sale | $1,148,503 | -4,581 | -29% | $250.71 | 11,372 | 20 May 2025 | Direct | F1, F3 |
| holding | STE | Ordinary Shares | 67 | 20 May 2025 | See Footnote Below | F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | STE | Employee Stock Option (right to buy) | Options Exercise | $0 | -12,828 | -100% | $0.000000 | 0 | 20 May 2025 | Ordinary Shares | 12,828 | $147.05 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | As of May 20, 2025, 9,872 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,964 on June 2, 2025; 692 on October 1, 2025; 2,697 on June 1, 2026; 2,140 on June 2, 2026 and 2,379 on June 4, 2027. |
| F2 | Price reflects a weighted average sale price for multiple transactions ranging from $249.46 to $250.17 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F3 | Price reflects a weighted average sale price for multiple transactions ranging from $250.50 to $251.04 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F4 | Units representing 67 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of May 20, 2025. |
| F5 | This option is fully vested. |